Search

everythinglearnresearchcommunity

for

Search:↓

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Using finasteride with TIP extends time off period for prostate cancer patients.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

CEC levels may be a useful marker for predicting prostate cancer progression.

Gene variation affects prostate issues and hair loss.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride can treat prostatic haematuria, but its use is controversial.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.